Moreover, the inhibitory receptors such as PD-1 were significantly increased in tumor tissues derived from digestive cancer patients, including the esophageal squamous-cell carcinomas (ESCC), HCC, CRC, GC, and biliary cancer [43]. This evidence concerns the gene PDCD1 and neoplasm.